SCYNEXIS Statistics
Total Valuation
SCYNEXIS has a market cap or net worth of $39.76 million. The enterprise value is -$3.27 million.
Important Dates
The next estimated earnings date is Wednesday, May 7, 2025, after market close.
| Earnings Date | May 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SCYNEXIS has 38.98 million shares outstanding. The number of shares has increased by 0.25% in one year.
| Current Share Class | 38.98M |
| Shares Outstanding | 38.98M |
| Shares Change (YoY) | +0.25% |
| Shares Change (QoQ) | +0.11% |
| Owned by Insiders (%) | 1.54% |
| Owned by Institutions (%) | 25.67% |
| Float | 36.14M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 13.21 |
| Forward PS | 0.52 |
| PB Ratio | 0.70 |
| P/TBV Ratio | 0.72 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.00, with a Debt / Equity ratio of 0.30.
| Current Ratio | 3.00 |
| Quick Ratio | 2.89 |
| Debt / Equity | 0.30 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -14.53 |
Financial Efficiency
Return on equity (ROE) is -33.25% and return on invested capital (ROIC) is -29.14%.
| Return on Equity (ROE) | -33.25% |
| Return on Assets (ROA) | -21.18% |
| Return on Invested Capital (ROIC) | -29.14% |
| Return on Capital Employed (ROCE) | -55.78% |
| Revenue Per Employee | $133,786 |
| Profits Per Employee | -$760,286 |
| Employee Count | 28 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SCYNEXIS has paid $151,000 in taxes.
| Income Tax | 151,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -32.00% in the last 52 weeks. The beta is 1.72, so SCYNEXIS's price volatility has been higher than the market average.
| Beta (5Y) | 1.72 |
| 52-Week Price Change | -32.00% |
| 50-Day Moving Average | 0.98 |
| 200-Day Moving Average | 1.33 |
| Relative Strength Index (RSI) | 56.82 |
| Average Volume (20 Days) | 109,270 |
Short Selling Information
The latest short interest is 747,205, so 1.92% of the outstanding shares have been sold short.
| Short Interest | 747,205 |
| Short Previous Month | 695,229 |
| Short % of Shares Out | 1.92% |
| Short % of Float | 2.07% |
| Short Ratio (days to cover) | 5.68 |
Income Statement
In the last 12 months, SCYNEXIS had revenue of $3.75 million and -$21.29 million in losses. Loss per share was -$0.44.
| Revenue | 3.75M |
| Gross Profit | 3.75M |
| Operating Income | -37.12M |
| Pretax Income | -34.72M |
| Net Income | -21.29M |
| EBITDA | -36.54M |
| EBIT | -37.12M |
| Loss Per Share | -$0.44 |
Full Income StatementBalance Sheet
The company has $59.30 million in cash and $16.27 million in debt, giving a net cash position of $43.03 million or $1.10 per share.
| Cash & Cash Equivalents | 59.30M |
| Total Debt | 16.27M |
| Net Cash | 43.03M |
| Net Cash Per Share | $1.10 |
| Equity (Book Value) | 55.08M |
| Book Value Per Share | 1.45 |
| Working Capital | 48.08M |
Full Balance SheetCash Flow
| Operating Cash Flow | -24.01M |
| Capital Expenditures | n/a |
| Free Cash Flow | -24.01M |
| FCF Per Share | -$0.62 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -990.84% |
| Pretax Margin | -564.26% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |